The frequency of low HER2 expression in breast cancer and a comparison of prognosis between patients with HER2-low and HER2-negative breast cancer by HR status.

Nanae HorisawaYayoi AdachiDaiki TakatsukaKazuki NozawaYuka EndoYuri OzakiKayoko SuginoAyumi KataokaHaruru KotaniAkiyo YoshimuraMasaya HattoriMasataka SawakiHiroji Iwata

Published in: Breast cancer (Tokyo, Japan) (2021)

HER2-low patients did not have a significantly different prognosis than HER2-0 patients, regardless of HR status. However, we should consider tailoring therapies for patients with HRE2-low early breast cancer according to their HR status.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
peritoneal dialysis
prognostic factors
poor prognosis
early breast cancer
long non coding rna
binding protein